Therapie des hormonrefraktären Prostatakarzinoms
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00120-005-0980-8.pdf
Reference59 articles.
1. Aus G, Abbou CC, Bolla M et al. (2005) EAU Guidelines on prostate cancer. Eur Urol 48:546–551
2. Benson R, Hartley-Asp B (1990) Mechanisms of action and clinical uses of estramustine. Cancer Invest 8:375
3. Berrutti A, Dogliotti L, Bitossi R et al. (2000) Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. J Urol 164:1248–1253
4. Berry W, Dakhil S, Modiano M et al. (2002). Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer. J Urol 168:2439–2443
5. Bland LB, Tangen CM, Thompson IM et al. (2004) Prognostic value of anemia in untreated metastatic prostate cancer: a mukltivariate analysis of SWOG 8894. Proc ASCO 23:399
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efectividad y tolerabilidad del ácido zoledrónico en el tratamiento del cancer de próstata metastásico;Actas Urológicas Españolas;2008-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3